NCT02675647View on ClinicalTrials.gov

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions
Cardiac SurgeryCardiopulmonary BypassObese Patients (BMI ≥ 30 kg/m²)
Interventions
DRUG

Heparin, IV route, based on patients body weights (UI/kg)

PROCEDURE

Cardiopulmonary bypass

DRUG

Protamin administration

Trial Locations (1)

67091

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT02675647 - Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients | Biotech Hunter | Biotech Hunter